Medicare Program; Public Meeting in Calendar Year 2010 for New Clinical Laboratory Tests Payment Determinations, 30041-30043 [2010-12458]
Download as PDF
Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of ‘‘Member Conflict Review, PA
07–318.’’
Contact Person for More Information: M.
Chris Langub, PhD, Scientific Review
Administrator, Office of Extramural
Programs, National Institute for Occupational
Safety and Health, CDC, 1600 Clifton Road,
NE., Mailstop E74, Atlanta, Georgia 30333;
Telephone: (404)498–2543.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 20, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–12829 Filed 5–27–10; 8:45 am]
Disease, Disability, and Injury
Prevention and Control
jlentini on DSKJ8SOYB1PROD with NOTICES
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Medicare Program; Public Meeting in
Calendar Year 2010 for New Clinical
Laboratory Tests Payment
Determinations
Centers for Disease Control and
Prevention
Special Emphasis Panel (SEP):
Effectiveness of Empiric Antiviral
Treatment for Hospitalized Community
Acquired Pneumonia during the
Influenza Season, Funding Opportunity
Announcement (FOA) IP10–007, Initial
Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12 p.m.–2 p.m., June
15, 2010 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Effectiveness of Empiric Antiviral
Treatment for Hospitalized Community
Jkt 220001
[FR Doc. 2010–12827 Filed 5–27–10; 8:45 am]
[CMS–1340–N]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
17:43 May 27, 2010
Dated: May 20, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Centers for Medicare & Medicaid
Services
BILLING CODE 4163–18–P
VerDate Mar<15>2010
Acquired Pneumonia during the
Influenza Season, FOA IP10–007’’.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, GA 30333, Telephone: (404)
498–2293.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
AGENCY: Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
SUMMARY: This notice announces a
public meeting to receive comments and
recommendations (including
accompanying data on which
recommendations are based) from the
public on the appropriate basis for
establishing payment amounts for a
specified list of new Clinical Procedural
Terminology (CPT) codes for clinical
laboratory tests in calendar year (CY)
2011. The meeting provides a forum for
interested parties to make presentations
and submit written comments on the
new codes that will be included in
Medicare’s Clinical Laboratory Fee
Schedule for CY 2011, which will be
effective on January 1, 2011. The
development of the codes for clinical
laboratory tests is largely performed by
the CPT Editorial Panel and will not be
further discussed at the meeting.
DATES: Meeting Date: The public
meeting is scheduled for Thursday, July
22, 2010 from 9 a.m. to 2 p.m., Eastern
Standard Time (E.S.T.).
Deadline for Registration of
Presenters: All presenters for the public
meeting must register by July 16, 2010.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
30041
Deadline for Submitting Requests for
Special Accommodations: Requests for
special accommodations must be
received no later than 5 p.m., E.S.T. on
July 16, 2010.
Deadline for Submission of Written
Comments: Interested parties may
submit written comments on the
proposed payment determinations by
September 24, 2010, to the address
specified in the ADDRESSES section of
this notice.
ADDRESSES: The public meeting will be
held in the main auditorium of the
central building of the Centers for
Medicare & Medicaid Services (CMS),
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
FOR FURTHER INFORMATION CONTACT:
Glenn McGuirk, (410) 786–5723.
SUPPLEMENTARY INFORMATION:
I. Background
Section 531(b) of the Medicare,
Medicaid, and SCHIP Benefits
Improvement and Protection Act of
2000 (BIPA) (Pub. L. 106–554) requires
the Secretary to establish procedures for
coding and payment determinations for
new clinical diagnostic laboratory tests
under Part B of title XVIII of the Social
Security Act (the Act) that permit public
consultation in a manner consistent
with the procedures established for
implementing coding modifications for
International Classification of Diseases
(ICD–9–CM). The procedures and public
meeting announced in this notice for
new clinical laboratory tests are in
accordance with the procedures
published on November 23, 2001 in the
Federal Register (66 FR 58743) to
implement section 531(b) of BIPA.
Section 942(b) of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173) added section 1833(h)(8) of
the Act. Section 1833(h)(8)(A) of the Act
states that such new tests are any
clinical diagnostic laboratory tests with
respect to which a new or substantially
revised Healthcare Common Procedures
Coding System (HCPCS) code is
assigned on or after January 1, 2005
(hereinafter referred to as, ‘‘new test’’ or
‘‘new clinical laboratory test’’). Section
1833(h)(8)(B) of the Act sets forth the
methods for determining payment bases
for new tests. Pertinent to this notice,
section 1833(h)(8)(B)(i) and (ii) of the
Act requires the Secretary to make
available to the public a list that
includes new tests for which
establishment of a payment amount is
being considered for a year and, on the
same day that the list is made available,
to publish in the Federal Register a
notice of a meeting to receive comments
E:\FR\FM\28MYN1.SGM
28MYN1
30042
Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices
jlentini on DSKJ8SOYB1PROD with NOTICES
and recommendations (including
accompanying data on which
recommendations are based) from the
public on the appropriate basis for
establishing payment amounts for new
tests. Section 1833(h)(8)(B)(iii) of the
Act requires that we convene a public
meeting not less than 30 days after
publication of the notice in the Federal
Register. These requirements are
codified at 42 CFR part 414, subpart G.
A newly created Current Procedural
Terminology (CPT) code can represent
either a refinement or modification of
existing test methods, or a substantially
new test method. The preliminary list of
newly created CPT codes for calendar
year (CY) 2011 will be published on our
Web site at https://www.cms.hhs.gov/
ClinicalLabFeeSched upon publication
of this notice in the Federal Register.
Two methods are used to establish
payment amounts for new tests
included in the CY 2011 Clinical
Laboratory Fee Schedule. The first
method, called ‘‘cross-walking,’’ is used
when a new test is determined to be
comparable to an existing test, multiple
existing test codes, or a portion of an
existing test code. The new test code is
then assigned to the related existing
local fee schedule amounts and the
related existing national limitation
amount. Payment for the new test is
made at the lesser of the local fee
schedule amount or the national
limitation amount.
The second method, called ‘‘gapfilling,’’ is used when no comparable
existing test is available. When using
this method, instructions are provided
to each Medicare carrier or Part A and
Part B Medicare Administrative
Contractor (MAC) to determine a
payment amount for its geographic
area(s) for use in the first year. These
determinations are based on the
following sources of information, if
available: Charges for the test and
routine discounts to charges; resources
required to perform the test; payment
amounts determined by other payers;
and charges, payment amounts, and
resources required for other tests that
may be comparable or otherwise
relevant. The carrier-specific amounts
are used to establish a national
limitation amount for the following
years. For each new clinical laboratory
test code, a determination must be made
to either cross-walk or gap-fill.
II. Format
This meeting to receive comments
and recommendations (including
accompanying data on which
recommendations are based) on the
appropriate payment basis for the
specified list of new CPT codes is open
VerDate Mar<15>2010
17:43 May 27, 2010
Jkt 220001
to the public. The on-site check-in for
visitors will be held from 8:30 a.m.,
E.S.T. to 9 a.m., E.S.T., followed by
opening remarks. Registered persons
from the public may discuss and
recommend payment determinations for
specific new test codes for the CY 2011
Clinical Laboratory Fee Schedule.
Presentations must be brief and
accompanied by three written copies.
CMS recommends that presenters make
copies available for approximately 50
meeting participants, since CMS will
not be providing additional copies.
Before the annual meeting on July 22,
2010, presentations must also be
electronically submitted to CMS on or
before July 2, 2010. Presentations
should be sent via e-mail to Glenn
McGuirk, at
Glenn.McGuirk@cms.hhs.gov. Once the
presentations are collected, CMS will
post them on the Clinical Laboratory
Web site at https://www.cms.hhs.gov/
ClinicalLabFeeSched. Presenters should
address the following items:
• New test code(s) and descriptor;
• Test purpose and method;
• Costs;
• Charges; and
• Make a recommendation with
rationale for one of two methods (crosswalking or gap-fill) for determining
payment for new tests.
Additionally, the presenters should
provide the data on which their
recommendations are based.
Presentations that do not address the
above five items may be considered
incomplete and may not be considered
by CMS when making a payment
determination. CMS may request
missing information following the
meeting in order to prevent a
recommendation from being considered
incomplete.
A summary of the proposed new test
codes and the payment
recommendations that are presented
during the public meeting will be
posted on the CMS Web site by early
September 2010 and can be accessed at
https://www.cms.hhs.gov/
ClinicalLabFeeSched.
In addition, the summary on the CMS
Web site will also include a list of all
comments received by August 6, 2010
(15 days after the meeting). The
summary will also display our proposed
payment determinations, an explanation
of the reasons for each determination,
and the data on which the
determinations are based. Interested
parties may submit written comments
on the proposed payment
determinations by September 24, 2010,
to the address specified in the
ADDRESSES section of this notice. Final
payment determinations will be posted
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
on our Web site in October 2010. Each
determination will include a rationale,
data on which the determination is
based, and responses to comments and
suggestions received from the public.
After the final payment
determinations have been posted on our
Web site, the public may request
reconsideration of the payment
determinations as set forth in 42 CFR
414.509. We also refer readers to the
November 27, 2007 final rule (72 FR
66275 through 66280).
III. Registration Instructions
The Division of Ambulatory Services
in CMS is coordinating the public
meeting registration. Beginning June 22,
2010, registration may be completed online at the following Web address:
https://www.cms.hhs.gov/
ClinicalLabFeeSched. The following
information must be submitted when
registering:
• Name;
• Company name;
• Address;
• Telephone number(s); and
• E-mail address(es).
When registering, individuals who
want to make a presentation must also
specify on which new clinical
laboratory test code(s) they will be
presenting comments. A confirmation
will be sent upon receipt of the
registration. Individuals must register by
the date specified in the DATES section
of this notice.
IV. Security, Building, and Parking
Guidelines
The meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security. It is suggested that you
arrive at the CMS facility between 8:15
a.m and 8:30 a.m., E.S.T. so that you
will be able to arrive promptly at the
meeting by 9 a.m., E.S.T. Individuals
who are not registered in advance will
not be permitted to enter the building
and will be unable to attend the
meeting. The public may not enter the
building earlier than 8:15 a.m., E.S.T.
(45 minutes before the convening of the
meeting).
Security measures include the
following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel. Persons without
proper identification may be denied
access to the building.
• Interior and exterior inspection of
vehicles (this includes engine and trunk
inspection) at the entrance to the
E:\FR\FM\28MYN1.SGM
28MYN1
Federal Register / Vol. 75, No. 103 / Friday, May 28, 2010 / Notices
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Passing through a metal detector
and inspection of items brought into the
building. We note that all items brought
to CMS, whether personal or for the
purpose of demonstration or to support
a demonstration, are subject to
inspection. We cannot assume
responsibility for coordinating the
receipt, transfer, transport, storage, setup, safety, or timely arrival of any
personal belongings or items used for
demonstration or to support a
demonstration.
V. Special Accommodations
Individuals attending the meeting
who are hearing or visually impaired
and have special requirements, or a
condition that requires special
assistance, should provide the
information upon registering for the
meeting. The deadline for such
registrations is listed in the DATES
section of this notice.
VI. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: May 7, 2010.
Marilyn Tavenner,
Acting Administrator and Chief Operating
Officer, Centers for Medicare & Medicaid
Services.
FOR FURTHER INFORMATION CONTACT
[FR Doc. 2010–12458 Filed 5–27–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7018–N]
jlentini on DSKJ8SOYB1PROD with NOTICES
Medicare Program; Meeting of the
Advisory Panel on Medicare Education
June 22, 2010.
AGENCY: Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
SUMMARY: This notice announces a
meeting of the Advisory Panel on
VerDate Mar<15>2010
17:43 May 27, 2010
Jkt 220001
Medicare Education (the Panel) in
accordance with the Federal Advisory
Committee Act. The Panel advises and
makes recommendations to the
Secretary of Health and Human Services
and the Administrator of the Centers for
Medicare & Medicaid Services on
opportunities to enhance the
effectiveness of consumer education
strategies concerning the Medicare
program. This meeting is open to the
public.
DATES: Meeting Date: Tuesday, June 22,
2010 from 8:30 a.m. to 3 p.m., eastern
daylight time (e.d.t.).
Deadline for Meeting Registration,
Presentations and Comments: Tuesday,
June 15, 2010, 5 p.m., e.d.t.
Deadline for Requesting Special
Accommodations: Tuesday, June 8,
2009, 5 p.m., e.d.t.
ADDRESSES: Meeting Location: Hilton
Washington Hotel Embassy Row, 2015
Massachusetts Avenue, NW.,
Washington, DC 20036.
Meeting Registration, Presentations,
and Written Comments: Cindy Falconi,
Acting Designated Federal Official
(DFO), Division of Forum and
Conference Development, Office of
External Affairs, Centers for Medicare &
Medicaid Services, 7500 Security
Boulevard, Mailstop S1–13–05,
Baltimore, MD 21244–1850 or contact
Ms. Falconi via e-mail at
Cindy.Falconi@cms.hhs.gov.
Registration: The meeting is open to
the public, but attendance is limited to
the space available. Persons wishing to
attend this meeting must register by
contacting the DFO at the address listed
in the ADDRESSES section of this notice
or by telephone at number listed in the
section of this notice, by the date listed
in the DATES section of this notice.
FOR FURTHER INFORMATION CONTACT:
Cindy Falconi, (410) 786–6452. Please
refer to the CMS Advisory Committees’
Information Line (1–877–449–5659 toll
free)/(410–786–9379 local) or the
Internet (https://www.cms.hhs.gov/
FACA/04_APME.asp) for additional
information and updates on committee
activities. Press inquiries are handled
through the CMS Press Office at (202)
690–6145.
SUPPLEMENTARY INFORMATION: Section
9(a)(2) of the Federal Advisory
Committee Act authorizes the Secretary
of Health and Human Services (the
Secretary) to establish an advisory panel
if the Secretary determines that the
panel is ‘‘in the public interest in
connection with the performance of
duties imposed * * * by law.’’ Such
duties are imposed by section 1804 of
the Social Security Act (the Act),
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
30043
requiring the Secretary to provide
informational materials to Medicare
beneficiaries about the Medicare
program, and section 1851(d) of the Act,
requiring the Secretary to provide for
‘‘activities * * * to broadly disseminate
information to [M]edicare beneficiaries
* * * on the coverage options provided
under [Medicare Advantage] in order to
promote an active, informed selection
among such options.’’
The Panel is also authorized by
section 1114(f) of the Act (42 U.S.C.
1311(f)) and section 222 of the Public
Health Service Act (42 U.S.C. 217a). The
Secretary signed the charter establishing
this Panel on January 21, 1999 (64 FR
7899, February 17, 1999) and approved
the renewal of the charter on January 21,
2009 (74 FR 13442, March 27, 2009).
The Panel advises and makes
recommendations to the Secretary and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
opportunities to enhance the
effectiveness of consumer education
strategies concerning the Medicare
program.
The goals of the Panel are as follows:
• To provide recommendations on
the development and implementation of
a national Medicare education program
that describes benefit options under
Medicare.
• To enhance the Federal
government’s effectiveness in informing
the Medicare consumer.
• To make recommendations on how
to expand outreach to vulnerable and
underserved communities, including
racial and ethnic minorities, in the
context of a national Medicare
education program.
• To assemble an information base of
best practices for helping consumers
evaluate benefit options and build a
community infrastructure for
information, counseling, and assistance.
The current members of the Panel are:
Gwendolyn T. Bronson, SHINE/SHIP
Counselor, Massachusetts SHINE
Program; Yanira Cruz, PhD, President
and Chief Executive Officer, National
Hispanic Council on Aging; Stephen P.
Fera, M.B.A., Vice President, Social
Mission Programs, Independence Blue
Cross; Nan-Kirsten Forte, Executive Vice
President, Consumer Services, WebMD;
Richard C. Frank, M.D., Director, Cancer
Research, Whittingham Cancer Center;
Cathy C. Graeff, R.Ph., M.B.A., Partner,
Sonora Advisory Group; Carmen R.
Green, M.D., Professor, Anesthesiology
and Associate Professor, Health,
Management, and Policy, University of
Michigan; Jessie C. Gruman, PhD,
President, Center for Advancing Health;
Cindy Hounsell, J.D., President,
Women’s Institute for a Secure
E:\FR\FM\28MYN1.SGM
28MYN1
Agencies
[Federal Register Volume 75, Number 103 (Friday, May 28, 2010)]
[Notices]
[Pages 30041-30043]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-12458]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1340-N]
Medicare Program; Public Meeting in Calendar Year 2010 for New
Clinical Laboratory Tests Payment Determinations
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting to receive comments and
recommendations (including accompanying data on which recommendations
are based) from the public on the appropriate basis for establishing
payment amounts for a specified list of new Clinical Procedural
Terminology (CPT) codes for clinical laboratory tests in calendar year
(CY) 2011. The meeting provides a forum for interested parties to make
presentations and submit written comments on the new codes that will be
included in Medicare's Clinical Laboratory Fee Schedule for CY 2011,
which will be effective on January 1, 2011. The development of the
codes for clinical laboratory tests is largely performed by the CPT
Editorial Panel and will not be further discussed at the meeting.
DATES: Meeting Date: The public meeting is scheduled for Thursday, July
22, 2010 from 9 a.m. to 2 p.m., Eastern Standard Time (E.S.T.).
Deadline for Registration of Presenters: All presenters for the
public meeting must register by July 16, 2010.
Deadline for Submitting Requests for Special Accommodations:
Requests for special accommodations must be received no later than 5
p.m., E.S.T. on July 16, 2010.
Deadline for Submission of Written Comments: Interested parties may
submit written comments on the proposed payment determinations by
September 24, 2010, to the address specified in the ADDRESSES section
of this notice.
ADDRESSES: The public meeting will be held in the main auditorium of
the central building of the Centers for Medicare & Medicaid Services
(CMS), 7500 Security Boulevard, Baltimore, Maryland 21244-1850.
FOR FURTHER INFORMATION CONTACT: Glenn McGuirk, (410) 786-5723.
SUPPLEMENTARY INFORMATION:
I. Background
Section 531(b) of the Medicare, Medicaid, and SCHIP Benefits
Improvement and Protection Act of 2000 (BIPA) (Pub. L. 106-554)
requires the Secretary to establish procedures for coding and payment
determinations for new clinical diagnostic laboratory tests under Part
B of title XVIII of the Social Security Act (the Act) that permit
public consultation in a manner consistent with the procedures
established for implementing coding modifications for International
Classification of Diseases (ICD-9-CM). The procedures and public
meeting announced in this notice for new clinical laboratory tests are
in accordance with the procedures published on November 23, 2001 in the
Federal Register (66 FR 58743) to implement section 531(b) of BIPA.
Section 942(b) of the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub. L. 108-173) added section
1833(h)(8) of the Act. Section 1833(h)(8)(A) of the Act states that
such new tests are any clinical diagnostic laboratory tests with
respect to which a new or substantially revised Healthcare Common
Procedures Coding System (HCPCS) code is assigned on or after January
1, 2005 (hereinafter referred to as, ``new test'' or ``new clinical
laboratory test''). Section 1833(h)(8)(B) of the Act sets forth the
methods for determining payment bases for new tests. Pertinent to this
notice, section 1833(h)(8)(B)(i) and (ii) of the Act requires the
Secretary to make available to the public a list that includes new
tests for which establishment of a payment amount is being considered
for a year and, on the same day that the list is made available, to
publish in the Federal Register a notice of a meeting to receive
comments
[[Page 30042]]
and recommendations (including accompanying data on which
recommendations are based) from the public on the appropriate basis for
establishing payment amounts for new tests. Section 1833(h)(8)(B)(iii)
of the Act requires that we convene a public meeting not less than 30
days after publication of the notice in the Federal Register. These
requirements are codified at 42 CFR part 414, subpart G.
A newly created Current Procedural Terminology (CPT) code can
represent either a refinement or modification of existing test methods,
or a substantially new test method. The preliminary list of newly
created CPT codes for calendar year (CY) 2011 will be published on our
Web site at https://www.cms.hhs.gov/ClinicalLabFeeSched upon publication
of this notice in the Federal Register.
Two methods are used to establish payment amounts for new tests
included in the CY 2011 Clinical Laboratory Fee Schedule. The first
method, called ``cross-walking,'' is used when a new test is determined
to be comparable to an existing test, multiple existing test codes, or
a portion of an existing test code. The new test code is then assigned
to the related existing local fee schedule amounts and the related
existing national limitation amount. Payment for the new test is made
at the lesser of the local fee schedule amount or the national
limitation amount.
The second method, called ``gap-filling,'' is used when no
comparable existing test is available. When using this method,
instructions are provided to each Medicare carrier or Part A and Part B
Medicare Administrative Contractor (MAC) to determine a payment amount
for its geographic area(s) for use in the first year. These
determinations are based on the following sources of information, if
available: Charges for the test and routine discounts to charges;
resources required to perform the test; payment amounts determined by
other payers; and charges, payment amounts, and resources required for
other tests that may be comparable or otherwise relevant. The carrier-
specific amounts are used to establish a national limitation amount for
the following years. For each new clinical laboratory test code, a
determination must be made to either cross-walk or gap-fill.
II. Format
This meeting to receive comments and recommendations (including
accompanying data on which recommendations are based) on the
appropriate payment basis for the specified list of new CPT codes is
open to the public. The on-site check-in for visitors will be held from
8:30 a.m., E.S.T. to 9 a.m., E.S.T., followed by opening remarks.
Registered persons from the public may discuss and recommend payment
determinations for specific new test codes for the CY 2011 Clinical
Laboratory Fee Schedule.
Presentations must be brief and accompanied by three written
copies. CMS recommends that presenters make copies available for
approximately 50 meeting participants, since CMS will not be providing
additional copies. Before the annual meeting on July 22, 2010,
presentations must also be electronically submitted to CMS on or before
July 2, 2010. Presentations should be sent via e-mail to Glenn McGuirk,
at Glenn.McGuirk@cms.hhs.gov. Once the presentations are collected, CMS
will post them on the Clinical Laboratory Web site at https://www.cms.hhs.gov/ClinicalLabFeeSched. Presenters should address the
following items:
New test code(s) and descriptor;
Test purpose and method;
Costs;
Charges; and
Make a recommendation with rationale for one of two
methods (cross-walking or gap-fill) for determining payment for new
tests.
Additionally, the presenters should provide the data on which their
recommendations are based. Presentations that do not address the above
five items may be considered incomplete and may not be considered by
CMS when making a payment determination. CMS may request missing
information following the meeting in order to prevent a recommendation
from being considered incomplete.
A summary of the proposed new test codes and the payment
recommendations that are presented during the public meeting will be
posted on the CMS Web site by early September 2010 and can be accessed
at https://www.cms.hhs.gov/ClinicalLabFeeSched.
In addition, the summary on the CMS Web site will also include a
list of all comments received by August 6, 2010 (15 days after the
meeting). The summary will also display our proposed payment
determinations, an explanation of the reasons for each determination,
and the data on which the determinations are based. Interested parties
may submit written comments on the proposed payment determinations by
September 24, 2010, to the address specified in the ADDRESSES section
of this notice. Final payment determinations will be posted on our Web
site in October 2010. Each determination will include a rationale, data
on which the determination is based, and responses to comments and
suggestions received from the public.
After the final payment determinations have been posted on our Web
site, the public may request reconsideration of the payment
determinations as set forth in 42 CFR 414.509. We also refer readers to
the November 27, 2007 final rule (72 FR 66275 through 66280).
III. Registration Instructions
The Division of Ambulatory Services in CMS is coordinating the
public meeting registration. Beginning June 22, 2010, registration may
be completed on-line at the following Web address: https://www.cms.hhs.gov/ClinicalLabFeeSched. The following information must be
submitted when registering:
Name;
Company name;
Address;
Telephone number(s); and
E-mail address(es).
When registering, individuals who want to make a presentation must
also specify on which new clinical laboratory test code(s) they will be
presenting comments. A confirmation will be sent upon receipt of the
registration. Individuals must register by the date specified in the
DATES section of this notice.
IV. Security, Building, and Parking Guidelines
The meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. In planning your
arrival time, we recommend allowing additional time to clear security.
It is suggested that you arrive at the CMS facility between 8:15 a.m
and 8:30 a.m., E.S.T. so that you will be able to arrive promptly at
the meeting by 9 a.m., E.S.T. Individuals who are not registered in
advance will not be permitted to enter the building and will be unable
to attend the meeting. The public may not enter the building earlier
than 8:15 a.m., E.S.T. (45 minutes before the convening of the
meeting).
Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel. Persons without proper identification may be denied access
to the building.
Interior and exterior inspection of vehicles (this
includes engine and trunk inspection) at the entrance to the
[[Page 30043]]
grounds. Parking permits and instructions will be issued after the
vehicle inspection.
Passing through a metal detector and inspection of items
brought into the building. We note that all items brought to CMS,
whether personal or for the purpose of demonstration or to support a
demonstration, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for demonstration or to support a demonstration.
V. Special Accommodations
Individuals attending the meeting who are hearing or visually
impaired and have special requirements, or a condition that requires
special assistance, should provide the information upon registering for
the meeting. The deadline for such registrations is listed in the DATES
section of this notice.
VI. Collection of Information Requirements
This document does not impose information collection and
recordkeeping requirements. Consequently, it need not be reviewed by
the Office of Management and Budget under the authority of the
Paperwork Reduction Act of 1995 (44 U.S.C. 35).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: May 7, 2010.
Marilyn Tavenner,
Acting Administrator and Chief Operating Officer, Centers for Medicare
& Medicaid Services.
[FR Doc. 2010-12458 Filed 5-27-10; 8:45 am]
BILLING CODE 4120-01-P